The NAMPT inhibitor FK866 reverts the damage in spinal cord injury. - Wikidata - wikimedia - TriplyDB

The NAMPT inhibitor FK866 reverts the damage in spinal cord injury.

The NAMPT inhibitor FK866 reverts the damage in spinal cord injury.

http://www.wikidata.org/entity/Q42171829

about

Sirtuin deacylases: a molecular link between metabolism and immunity Nicotinamide phosphoribosyl transferase (Nampt) is a target of microRNA-26b in colorectal cancer cells Targeting of nicotinamide phosphoribosyltransferase enzymatic activity ameliorates lung damage induced by ischemia/reperfusion in rats Nicotinamide mononucleotide attenuates brain injury after intracerebral hemorrhage by activating Nrf2/HO-1 signaling pathway.Nicotinamide phosphoribosyltransferase inhibitor is a novel therapeutic candidate in murine models of inflammatory lung injury.Nicotinamide phosphoribosyltransferase may be involved in age-related brain diseases.New function for Escherichia coli xanthosine phophorylase (xapA): genetic and biochemical evidences on its participation in NAD(+) salvage from nicotinamide.Novel CoQ10 antidiabetic mechanisms underlie its positive effect: modulation of insulin and adiponectine receptors, Tyrosine kinase, PI3K, glucose transporters, sRAGE and visfatin in insulin resistant/diabetic rats.Traumatic Brain Injury Leads to Development of Parkinson's Disease Related Pathology in Mice MC-PPEA as a new and more potent inhibitor of CLP-induced sepsis and pulmonary inflammation than FK866.Biological activities of guanidine compounds, 2008 - 2012 update.Wallerian degeneration: an emerging axon death pathway linking injury and disease.Inhibitor of Nicotinamide Phosphoribosyltransferase Sensitizes Glioblastoma Cells to Temozolomide via Activating ROS/JNK Signaling Pathway.Regulation and Function of Extracellular Nicotinamide Phosphoribosyltransferase/Visfatin.

P2860

Q28283588-F1009585-A565-4908-88AB-642194E724FD Q28534961-D2F2434C-9AB3-405D-B89D-8FF5C1D10241 Q33602183-94F32120-E90C-45C8-B63B-C4F0056113D9 Q33677954-D6D49BFB-F010-4AEC-B96C-754548CE1EEB Q34103687-06A9459B-1C6A-4838-8A59-7942FE83C8AD Q34446797-E58F9895-439D-4E26-8616-BF7BFAEA6482 Q35088919-294567F5-15E8-4EEE-AE70-6FAE28AF0EFC Q35106778-CC2813AD-5A98-4C40-A858-8415195D8773 Q37334985-297E30E7-B3A5-42D0-B97E-0A1B4F0ACF25 Q37691630-8ECB9C54-062E-4B7C-9975-423C881FD0C9 Q38101620-320B7EDC-A3E8-420B-92C7-64661202B9AE Q38212791-9AE58711-6C75-47F5-B302-31A9896835DC Q38720863-C5F665BA-F14C-4451-99B9-304200B4FBD5 Q39195646-F3A5AF3F-0BEE-4468-BC4F-D56D7FC3B71C

P2860

The NAMPT inhibitor FK866 reverts the damage in spinal cord injury.

http://www.wikidata.org/entity/Q42171829

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

The NAMPT inhibitor FK866 reverts the damage in spinal cord injury.

@en

The NAMPT inhibitor FK866 reverts the damage in spinal cord injury.

@nl

type

label

The NAMPT inhibitor FK866 reverts the damage in spinal cord injury.

@en

The NAMPT inhibitor FK866 reverts the damage in spinal cord injury.

@nl

prefLabel

The NAMPT inhibitor FK866 reverts the damage in spinal cord injury.

@en

The NAMPT inhibitor FK866 reverts the damage in spinal cord injury.

@nl

P1433

Q42171829-E12BBA1E-91C5-4BA9-96D6-31F02F858531

P1476

Q42171829-D638B1A0-A395-4650-B30E-A2AE81EE62F4

P2093

Q42171829-045197C9-4388-4261-8B04-A4AF6B7A7771

Q42171829-17E21D2A-3B1C-45F2-A9BB-18BF703C9D65

Q42171829-555F4D34-43C1-4976-B75C-503751D86971

Q42171829-8FCF19D8-DC55-4637-AC25-57812C642B12

Q42171829-DE14681D-9DD2-4C8A-82BB-5CED830736A2

Q42171829-E5D711D1-A0AC-443A-B68D-9D34F82B797B

P2860

Q42171829-0321C57F-EFA5-4345-94BA-ECAE3FF58610

Q42171829-1884810B-7F35-4689-BE57-2F0FEC5880F9

Q42171829-1EA8BF0A-9C07-4F9D-9705-FDD76237FC52

Q42171829-23CFB5CD-A011-499A-9544-7204ABB4AFB6

Q42171829-2AEFA10D-BDC4-4347-9D6C-B8FA378BF7A1

Q42171829-32B4A753-FA32-4A08-9711-9F729ECACD05

Q42171829-34754F4F-14D6-4416-BF88-2037864782BF

Q42171829-3ABD0A49-CADB-4C54-B7D6-7F5F53329ED1

Q42171829-3BFB447E-64CA-40C6-94BF-5B5D420C44F2

Q42171829-425BE628-D13B-42E7-B588-C0C1ED2E4DD6

P2888

Q42171829-FA2DB7B1-B3F7-4D08-B96A-403649E2C51E

P304

Q42171829-5114FFA2-73D0-42E2-8533-D12E67BB4BC7

P31

Q42171829-3B9B88C8-BF9D-4CAF-A5F1-8818B5A3A04B

P356

Q42171829-2E64BBDC-0D78-408C-9743-8740715FE736

P478

Q42171829-57840D28-D673-47A2-BC82-B2A01B157925

P50

Q42171829-35A6DB6D-FA4D-4664-AC89-11FA95AD4FF3

Q42171829-7FC7FFE7-C9BF-4AFA-9C1C-74E1126BF759

Q42171829-A2A58148-E1AE-4092-B439-0B116396EE27

P577

Q42171829-FC02AEAF-702F-4F3F-979A-3B87751EACF3

P5875

Q42171829-F76019C5-6262-4B85-BA0B-13D1E725D9E0

P6179

Q42171829-A000C27A-7949-475F-9DB8-DFB89FE5218B

P698

Q42171829-3F3E75DE-52D5-488B-A1D5-0CC5DEEEE3BF

P932

Q42171829-791DC699-B212-4124-B727-991A3C96BBFD

P356

P1433

Journal of Neuroinflammation

P1476

The NAMPT inhibitor FK866 reverts the damage in spinal cord injury.

@en

P2093

Cristina Travelli

http://www.w3.org/2001/XMLSchema#string

Daniela Impellizzeri

http://www.w3.org/2001/XMLSchema#string

Emanuela Esposito

http://www.w3.org/2001/XMLSchema#string

Gian Cesare Tron

http://www.w3.org/2001/XMLSchema#string

Gohar Fakhfouri

http://www.w3.org/2001/XMLSchema#string

Reza Rahimian

http://www.w3.org/2001/XMLSchema#string

P2860

Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme

Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor

Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis

Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease

Olprinone attenuates the acute inflammatory response and apoptosis after spinal cord trauma in mice

Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis.

Catastrophic NAD+ depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE.

Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury.

Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD

Opposing effects of sirtuins on neuronal survival: SIRT1-mediated neuroprotection is independent of its deacetylase activity

P2888

P304

66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1742-2094-9-66

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Armando A. Genazzani

Emanuela Mazzon

Salvatore Cuzzocrea

P577

2012-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223972266

http://www.w3.org/2001/XMLSchema#string

P6179

1042735016

http://www.w3.org/2001/XMLSchema#string

P698

22490786

http://www.w3.org/2001/XMLSchema#string

P932

3353188

http://www.w3.org/2001/XMLSchema#string